More articles from Psoriatic Arthritis

Open Access
Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Philip J. Mease, Taylor Blachley, Blessing Dube, Robert R. McLean, Nina Kim, Peter Hur and Alexis Ogdie

The Journal of Rheumatology July 1 2022, 49 (7) 700-706; DOI: https://doi.org/10.3899/jrheum.211033
Open Access
Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis
Philip J. Mease, Arthur Kavanaugh, Alexis Ogdie, Alvin F. Wells, Martin Bergman, Dafna D. Gladman, Sven Richter, Lichen Teng, Shauna Jardon and Josef S. Smolen

The Journal of Rheumatology July 1 2022, 49 (7) 694-699; DOI: https://doi.org/10.3899/jrheum.210906
Open Access
Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs
Majed M. Khraishi, Valencia P. Remple, Samuel Silverberg, Jacqueline C. Stewart, Brandusa Florica and Louis Bessette

The Journal of Rheumatology May 1 2022, 49 (5) 454-464; DOI: https://doi.org/10.3899/jrheum.200609
Open Access
Evaluation of Clinical Diagnosis of Axial Psoriatic Arthritis (PsA) or Elevated Patient-reported Spine Pain in CorEvitas’ PsA/Spondyloarthritis Registry
Alexis Ogdie, Taylor Blachley, Paul R. Lakin, Blessing Dube, Robert R. McLean, Peter Hur and Philip J. Mease

The Journal of Rheumatology March 1 2022, 49 (3) 281-290; DOI: https://doi.org/10.3899/jrheum.210662
You have access
The Association of Psoriatic Arthritis With All-cause Mortality and Leading Causes of Death in Psoriatic Arthritis
Amir Haddad, Walid Saliba, Idit Lavi, Amin Batheesh, Samir Kasem, Tal Gazitt, Ilan Feldhamer, Arnon Dov Cohen and Devy Zisman

The Journal of Rheumatology February 1 2022, 49 (2) 165-170; DOI: https://doi.org/10.3899/jrheum.210159
Open Access
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis
Proton Rahman, Christopher T. Ritchlin, Philip S. Helliwell, Wolf-Henning Boehncke, Philip J. Mease, Alice B. Gottlieb, Shelly Kafka, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie L. Xu, May Shawi, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Paraneedharan Ramachandran, Yanli Zhuang and Iain B. McInnes

The Journal of Rheumatology December 1 2021, 48 (12) 1815-1823; DOI: https://doi.org/10.3899/jrheum.201532
Open Access
Oligoarticular vs Polyarticular Psoriatic Arthritis: A Longitudinal Study Showing Similar Characteristics
Dafna D. Gladman, Justine Y. Ye, Vinod Chandran, Ker-Ai Lee and Richard J. Cook

The Journal of Rheumatology December 1 2021, 48 (12) 1824-1829; DOI: https://doi.org/10.3899/jrheum.210434
You have access
Measuring Physical Function in Psoriatic Arthritis: Comparing the Multidimensional Health Assessment Questionnaire to the Health Assessment Questionnaire–Disability Index
Weiyu Ye, Simon Hackett, Claire Vandevelde, Sarah Twigg, Philip S. Helliwell and Laura C. Coates

The Journal of Rheumatology November 1 2021, 48 (11) 1686-1691; DOI: https://doi.org/10.3899/jrheum.200927
You have access
Development of an Instrument for Patient Self-assessment in Psoriatic Arthritis
Farrouq Mahmood, Beverley English, Robin Waxman and Philip S. Helliwell

The Journal of Rheumatology November 1 2021, 48 (11) 1680-1685; DOI: https://doi.org/10.3899/jrheum.210010
Open Access
Canadian Rheumatologists’ Perspectives on Moderate Psoriatic Arthritis and Oligoarticular Psoriatic Arthritis
Dafna D. Gladman, Michael Starr, Alfred Cividino, Anne-Julie Gaudreau, Jennifer Jelley, Denise Nicholson and Jacob Karsh

The Journal of Rheumatology November 1 2021, 48 (11) 1692-1697; DOI: https://doi.org/10.3899/jrheum.201195

Main menu

User menu

Search

More articles from Psoriatic Arthritis

Pages

Content

Resources

Subscribers

More